Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…

Prognostic characteristics inform risk stratification in intensive care unit (ICU) patients with
coronavirus disease 2019 (COVID-19). We obtained blood samples (n = 474) from …

COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …

Background The safety and immunogenicity profile of COVID-19 vaccines when administered
concomitantly with seasonal influenza vaccines have not yet been reported. We therefore …

Background Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …

There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement
to existing diagnostic capabilities and for determining community seroprevalence. We …

Aims Coronavirus disease 2019 (COVID-19) can lead to multiorgan damage. MicroRNAs (miRNAs)
in blood reflect cell activation and tissue injury. We aimed to determine the …

The outcome of infection is dependent on the ability of viruses to manipulate the infected
cell to evade immunity, and the ability of the immune response to overcome this evasion. …

From its origins as a left-field, experimental, and even “maverick” intervention, faecal
microbiota transplantation (FMT) is now a well-recognised, accepted, and potentially life-saving …